does injection site matter for tirzepatide Rotation Map Where to Inject Tirzepatide: Injection

Plaintiffs contend that Novo Nordisk promoted Ozempic and Wegovy as miracle weight-loss drugs through massive advertising campaigns (including ubiquitous television commercials and print advertisements) while minimizing or omitting warnings about stomach paralysis, intestinal obstruction, and permanent blindness

A licensed healthcare provider reviews your information and determines if semaglutide is appropriate for you

A telehealth platform lets that person complete the intake process, connect with a licensed provider, and receive their first shipment without the delays that come with navigating a busy or inexperienced local practice

Sourced from Huberman Lab Ep 170

Heres what the research and my clinical experience reveal: Semaglutide is a well-established option with: Weekly injections Proven safety profile Average weight loss of 15-20% of body weight Effective appetite suppression Improvements in cardiovascular health markers Tirzepatide offers: Weekly injections Potentially greater weight loss (16-22.5% of body weight) Dual-action mechanism Similar side effect profile to semaglutide Enhanced metabolic benefits In a recent head-to-head trial , tirzepatide demonstrated superior weight loss compared to semaglutide, with participants losing an average of 20.2% versus 13.7% of their body weight at 72 weeks

That discovery, coupled with recent federal approvals for obesity treatment, helped propel them into the mainstream